Functional oesophageal epithelial defense against acid
- PMID: 16259724
- DOI: 10.1163/156856005774423953
Functional oesophageal epithelial defense against acid
Abstract
Functional oesophageal epithelial defense, including cell proliferation, restitution, buffers and ion transporters, plays a significant role in maintaining mucosal integrity and enabling rapid repair after injury. Growth factors such as epidermal growth factor (EGF), transforming growth factor-alpha (TGF-alpha), hepatocyte growth factor (HGF) and keratinocyte growth factor (KGF) are associated with oesophageal epithelial proliferation or restitution. Na+/H+ exchanger-1, an ion transporter, regulates intracellular pH and cell volume, and may have roles in cell proliferation, migration and survival. Cytokine, adhesion molecules, cyclooxygenase-2 and free radicals are associated with oesophageal inflammation and breach of the functional epithelial defense. Although the oesophagus does not have strong functional epithelial defense against acid, this defensive mechanisms may be involved in the pathogenesis of non-erosive gastro-oesophageal reflux disease. Medical therapy may be developed in future to enhance functional oesophageal epithelial defense.
Similar articles
-
The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.Aliment Pharmacol Ther. 2006 Jan 15;23(2):321-9. doi: 10.1111/j.1365-2036.2006.02747.x. Aliment Pharmacol Ther. 2006. PMID: 16393313
-
Increased expression of transforming growth factor-alpha and epidermal growth factor receptors in rat chronic reflux esophagitis.J Gastroenterol Hepatol. 2004 May;19(5):521-7. doi: 10.1111/j.1440-1746.2003.03332.x. J Gastroenterol Hepatol. 2004. PMID: 15086595
-
Mechanisms of oesophageal mucosal defence.Baillieres Best Pract Res Clin Gastroenterol. 2000 Oct;14(5):701-17. doi: 10.1053/bega.2000.0119. Baillieres Best Pract Res Clin Gastroenterol. 2000. PMID: 11003804 Review.
-
Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.Aliment Pharmacol Ther. 2004 Sep 15;20(6):637-43. doi: 10.1111/j.1365-2036.2004.02127.x. Aliment Pharmacol Ther. 2004. PMID: 15352912
-
Role of epidermal growth factor (EGF) in oesophageal mucosal integrity.Curr Med Res Opin. 1998;14(3):145-53. doi: 10.1185/03007999809113354. Curr Med Res Opin. 1998. PMID: 9787980 Review.
Cited by
-
OEsophageal Ion Transport Mechanisms and Significance Under Pathological Conditions.Front Physiol. 2020 Jul 16;11:855. doi: 10.3389/fphys.2020.00855. eCollection 2020. Front Physiol. 2020. PMID: 32765303 Free PMC article. Review.
-
Lack of Association between Epidermal Growth Factor or Its Receptor and Reflux Esophagitis, Barrett's Esophagus, and Esophageal Adenocarcinoma: A Case-Control Study.Dis Markers. 2022 Aug 31;2022:8790748. doi: 10.1155/2022/8790748. eCollection 2022. Dis Markers. 2022. PMID: 36092955 Free PMC article.
-
Cyclo-oxygenase-independent inhibition of apoptosis and stimulation of proliferation by leptin in human colon cancer cells.Dig Dis Sci. 2007 Aug;52(8):1934-45. doi: 10.1007/s10620-007-9784-6. Epub 2007 Apr 4. Dig Dis Sci. 2007. PMID: 17406816
-
Inhibition of NHE-1 Increases Smoke-Induced Proliferative Activity of Barrett's Esophageal Cell Line.Int J Mol Sci. 2021 Sep 30;22(19):10581. doi: 10.3390/ijms221910581. Int J Mol Sci. 2021. PMID: 34638919 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials